La COVID-19 est causée par un nouveau virus, le SARS-CoV-2 et frappe durement la population mondiale. Cette maladie soulève de nombreuses questions, dont celle de savoir si l’immunité développée par les personnes ayant guéri de la maladie permet de neutraliser efficacement le virus et d’assurer une protection à long terme. Dans le cadre de ce […]

The goal of this study will be to characterize a SARS-CoV2 antigen and the formulated drug product that will contain SARS-CoV2 antigen and a squalene-based adjuvant under tight timeline to release the material for COVID-19 vaccine clinical trials.

Our project aims to design and develop COVID19 vaccines engineered from viruses that infect bacterial cells only. SARS-CoV2 pathogenic components have been identified and modified to develop the vaccine. Although these components are pathogenic in nature, they are modified to pose no harm. The vaccine is designed to be administered intranasally, where it relocates to […]

The goal of the project is to facilitate the research and development of new drugs using machine learning. More specifically, exploring new techniques to model molecules and how they can be represented. Doing so will involve training deep learning models on multiple small datasets with the objective of improving the generalization performance on new tasks. […]

Dialogue is a virtual healthcare provider targeted towards the corporate environment. The service promotes employee wellness and productivity by connecting users to qualified healthcare professionals through an online or mobile application. The Dialogue service is increasingly being enhanced by AI techniques to improve user experience and streamline the procedure. These improvements include: • A Natural […]